| Literature DB >> 27988389 |
E J C Goldstein1, S J Johnson2, P-J Maziade3, C T Evans4, J C Sniffen5, M Millette6, L V McFarland7.
Abstract
The role of probiotics as adjunctive measures in the prevention of Clostridium difficile infection (CDI) has been controversial. However, a growing body of evidence has suggested that they have a role in primary prevention of CDI. Elements of this controversy are reviewed and the proposed mechanisms of action, the value and cost effectiveness of probiotics are addressed with a focus on three agents, Saccharomyces boulardii, Lactobacillus rhamnosus GG and the combination of Lactobacillus acidophilus CL1285, Lactobacillus casei LBC80R, Lactobacillus rhamnosus CLR2 (Bio-K+).Entities:
Keywords: Bio-K+; C. difficile; Lactobacillus acidophilus CL1285; Lactobacillus casei LBC80R; Lactobacillus rhamnosus CLR2; Lactobacillus rhamnosus GG; Probiotic; Saccharomyces boulardii
Mesh:
Year: 2016 PMID: 27988389 DOI: 10.1016/j.anaerobe.2016.12.007
Source DB: PubMed Journal: Anaerobe ISSN: 1075-9964 Impact factor: 3.331